A "Seismic Shift" in Longevity Science : Mainstream Acceptance + Large Funding

"You are incredibly prescient!" I woke up to those words from a former colleague on Jan. 19, 2022: the bombshell announcement that the Chief Science Officer of pharma giant GSK, where I worked until recently, will become the CEO at the new, $3 BILLION longevity science company Altos (presumably also funded by Amazon's Jeff Bezos.)

Big Pharma is at long last embracing Longevity Science. The corollary: longevity science is entering Mainstream (with capital "M")

But let me backtrack...

The Decade of Longevity Science

When Harvard professor David Sinclair declared the 2020's to be the "decade of the paradigm shift about age reversal", one could perhaps be dismissive of it as just an outburst of enthusiasm...

But in the past couple of years, we're seeing strong evidence that his forecast is right on the mark!

While I worked at GlaxoSmithKline - a giant, top-10, pharma company - I vigorously advocated forming a Longevity Science dept., and spoke to several VP's, senior VP's, and Hal Barron (the Chief Science Officer - yes, the one about to take the helm of Altos) himself a few times. He was friendly and very accessible, but non-committal... which puzzled me, given his large previous role at Google's longevity company Calico. I had a feeling he was up to something - something that he just couldn't yet reveal - INDEED!

Hal Barron, the CSO of mainstream Big Pharma GSK, is now about to become CEO of Altos...

Here is the official news announcement about Altos that earned me the "incredibly prescient" compliment I quoted at the opening.

Rousing the Sleeping Giant

When I first joined GSK, I was astonished - and yet not too surprised - that there wasn't a single mention of Longevity Science anywhere on the company's internal message boards : coming from small pioneering companies in the Longevity fields (in particular, my work at OpenCures.org, run by the co-founder of the SENS research foundation), I was very well aware of giant pharma's reputation as "being asleep at the wheel" when it came to Longevity Science...

Nonetheless, I quintuple-checked that indeed there was no group about longevity on GSK's "Workplace" (basically, a professional version of Facebook for internal company use), before starting one myself. I certainly didn't want to make a fool of myself by starting a group that was already in place!

On the company's "Workplace" platform, I found all sorts of groups on just about every imaginable subject - even Quantum Computers - but an absolute zero about longevity: "not even the smell of it", as my dad used to say! I consulted colleagues, management and top management - all the way to Hal Barron (friendly and very approachable, I was happy to discover), and indeed confirmed that no such group was in existence.

So, I started it: "Longevity Science & Business : Healthy Life Extension".

The group's cover image

I mirrored almost everything I posted there on my LinkedIn and professional Facebook account - with just slight tweaks for the different audience. For example, about:

the "tsunami" of investments flooding into Longevity Science
the inspiring interview of Harvard professor David Sinclair by prof. Brian Kennedy
the enzyme complex HTC that can inhibit cells from aging
the Longevity Investors Conference
the 170 or so longevity-science companies
science conferences such as the 8th Aging Research & Drug Discovery Meeting or the End Age-Related Diseases 2021
the 2018 World Health Organization move towards classifying aging as a disease

By the time I left GSK, the new group had grown to over 1,100 members - and I'm pleased to report that it inspired a number of colleagues, as well as university students considering career paths... and even got the attention of some top execs in the company.

I don't think that one can over-emphasize the importance of "rousing the sleeping giant" : that's of course a reference to the U.S. joining World War II (a fascinating topic I discuss in another blog entry.)

Whether you think highly of not of Big Pharma, there's no doubt that we "need all hands on deck" to fight a new "world war" : the war against the health decline of aging!

The Dawning of the Age of...

Aquarius? Maybe. But also the age of Mainstream for Longevity Science.

The importance of the Altos announcement goes well beyond the giant funding - important (obviously!) as that it... I personally think that this is a "seismic event" to bring longevity science into Mainstream with capital M!

It was one thing to have Hal Barron go from longevity companies (Calico) to big pharma... and a far bigger statement, imo, to go the other way 'round.
We are witnessing Longevity Science "coming of age" as Mainstream.

I shared the above sentiment with senior management at GSK, and was met with agreement.

I regard this juncture as a historical moment: the large funding of Altos, the prominent (alleged) participation of Jeff Bezos, and the equally prominent join at the helm of a big pharma Chief Science Officer! Plus a lot of other funding, rapid-fire research results, and a flurry of startup formation.

I've been waiting for this transition for a long time! When I wrote my first full article on Longevity Science, "mainstream" was not exactly the first word to came to mind - there was still an aura of "fringe" of science to fend off. During the intervening years, I've witnessed an incredible acceleration of advancement - and of entry into mainstream.

All said and done, I think we've finally left behind the era when Longevity Science was possibly regarded as "somewhat fringe", or "too out there", or "ahead of the times", or "extremely futuristic", etc!

Other Big Pharmas Hopping on the Train

I have no independent confirmation yet, but in a personal communication by a well-connected investor, whom I believe to be a reliable source, I was told that pharma giant Novartis is very interested in longevity science... and to some extent Roche also shares the interest.

Whether or not Big Pharma will actually lead innovation in Longevity Science, the "going mainstream" by itself is a major milestone!
Mainstream = funding, respect, academic participation, ditching the "cult-like" feel, completing the official reclassification of aging as a disease, etc.

Comments

Discussing Neuroscience with ChatGPT

UPDATED Apr. 2023 - I'm excited by ChatGPT 's possibilities in terms of facilitating advanced learning . For example, I got enlightening answers to questions that I had confronted when I first studied neuroscience. The examples below are taken from a very recent session I had with ChatGPT (mid Jan. 2023.) Source: https://neurosciencestuff.tumblr.com In case you're not familiar with ChatGPT, it's a very sophisticated "chatbot" - though, if you call it that way, it'll correct you! 'I am not a "chatbot", I am a language model, a sophisticated type of AI algorithm trained on vast amounts of text data to generate human-like text'. For a high-level explanation of how ChatGPT actually works - which also gives immense insight into its weaknesses, there's an excellent late Jan. 2023 talk by Stephen Wolfram, the brilliant author of the Mathematica software and of Wolfram Alpha , a product that could be combined with ChatGPT to imp

Using Schema in Graph Databases such as Neo4j

UPDATED Feb. 2024 - Graph databases have an easygoing laissez-faire attitude: "express yourself (almost) however you want"... By contrast, relational databases come across with an attitude like a micro-manager: "my way or the highway"... Is there a way to take the best of both worlds and distance oneself from their respective excesses, as best suited for one's needs? A way to marry the flexibility of Graph Databases and the discipline of Relational Databases? This article is part 5 of a growing, ongoing series on Graph Databases and Neo4j Let's Get Concrete Consider a simple scenario with scientific data such as the Sample, Experiment, Study, Run Result , where Samples are used in Experiments, and where Experiments are part of Studies and produce Run Results. That’s all very easy and intuitive to represent and store in a Labeled Graph Database such as Neo4j . For example, a rough draft might go like this: The “labels” (black tags) represent

Graph Databases (Neo4j) - a revolution in modeling the real world!

UPDATED Oct. 2023 - I was "married" to Relational Databases for many years... and it was a good "relationship" full of love and productivity - but SOMETHING WAS MISSING! Let me backtrack. In college, I got a hint of the "pre-relational database" days... Mercifully, that was largely before my time, but - primarily through a class - I got a taste of what the world was like before relational databases. It's an understatement to say: YUCK! Gratitude for the power and convenience of Relational Databases and SQL - and relief at having narrowly averted life before it! - made me an instant mega-fan of that technology. And for many years I held various jobs that, directly or indirectly, made use of MySQL and other relational databases - whether as a Database Administrator, Full-Stack Developer, Data Scientist, CTO or various other roles. UPDATE: This article is now part 1 of a growing, ongoing series on Graph Databases and Neo4j But ther

Anti-Aging Research: Science, not Hype

Last updated May 2023 Q: "How is aging a disease?" A: It's a dynamic system that veers away from its homeostasis (normal equilibrium point): hence a form of slow-progressing illness. Labeling it as 'natural' is a surrender to our traditional state of ignorance and powerlessness, which fortunately is beginning to be changed! Aging is "normal" only from the point of view of the "selfish gene", for whom the body is a disposable carrier. Individuals organisms - for whom self-preservation has a different meaning than for genes - have received scant help from evolution... with rare exceptions such as the T. dohrnii jellyfish (which I discuss here )... but now the time has finally arrived for our rational design to remedy some of the cellular flaws that evolution never bothered to correct! The above is my standard answer to an oft-asked question. The science of aging is by all evidence very misunderstood by the general public. Hype,

What are Graph Databases - and Why Should I Care?? : "Graph Databases for Poets"

This is a very gentle introduction to the subject. The subtitle is inspired by university courses such as "Physics for Poets"! (if you're technically inclined, there's an alternate article for you.) It has been said that "The language of physics (or of God) is math". On a similar note, it could be said that: The language of the biological world - or of any subject or endeavor involving complexity - is networks ('meshes') What is a network? Think of it as the familiar 'friends of friends' diagram from social media. Everywhere one turns in biology, there's a network – at the cellular level, tissue level, organ level, ecosystem level. The weather and other earth systems are networks. Human societal organization is a network. Electrical circuits, the Internet, our own brains... Networks are everywhere! What can we do with networks, to better understand the world around us, or to create something that we need? Broadly s

Using Neo4j with Python : the Open-Source Library "NeoAccess"

So, you want to build a python app or Jupyter notebook to utilize Neo4j, but aren't too keen on coding a lot of string manipulation to programmatic create ad-hoc Cypher queries? You're in the right place: the NeoAccess library can do take care of all that, sparing you from lengthy, error-prone development that requires substantial graph-database and software-development expertise! This article is part 4 of a growing, ongoing series on Graph Databases and Neo4j "NeoAccess" is the bottom layer of the technology stack provided by the BrainAnnex open-source project . All layers are very modular, and the NeoAccess library may also be used by itself , entirely separately from the rest of the technology stack. (A diagram of the full stack is shown later in this article.) NeoAccess interacts with the Neo4j Python driver , which is provided by the Neo4j company, to access the database from Python; the API to access that driver is very powerful, but complex - and does

Neo4j Sandbox Tutorial : try Neo4j and learn Cypher - free and easy!

So, you have an itch to test-drive Neo4j and its Cypher query language. Maybe you want to learn it, or evaluate it, or introduce colleagues/clients to it. And you wish for: fast, simple and free! Well, good news: the Neo4j company kindly provides a free, short-term hosted solution called "the Neo4j sandbox" . Extremely easy to set up and use! This article is part 2 of a growing, ongoing series on Graph Databases and Neo4j Register (free) for the Neo4j "Sandbox" Go to sandbox.neo4j.com , and register with a working email and a password. That's it! Note that this same email/password will also let you into the Neo4j Community Forums and Support ; the same login for all: very convenient! Launch your instance - blank or pre-populated After registering, go to sandbox.neo4j.com , and follow the steps in the diagram below (the choices might differ, but the "Blank Sandbox" should always be there): Too good to be true? Is there

Visualization of Graph Databases Using Cytoscape.js

(UPDATED APR. 2024) I have ample evidence from multiple sources that there are strong unmet needs in the area of visualization of graph databases. And whenever there's a vacuum, vendors circle like vultures - with incomplete, non-customizable, and at times ridiculously expensive, closed-box proprietary solutions. Fortunately, coming to the rescue is the awesome open-source cytoscape.js library , an offshoot of the "Cytoscape" project of the Institute for Systems Biology , a project with a long history that goes back to 2002. One can do amazing custom solutions, relatively easily, when one combines this Cytoscape library with: 1) a front-end framework such as Vue.js 2) backend libraries (for example in python) to prepare and serve the data For example, a while back I created a visualizer for networks of chemical reactions, for another open-source project I lead ( life123.science ) This visualizer will look and feel generally familiar to anyone who has eve

Neo4j & Cypher Tutorial : Getting Started with a Graph Database and its Query Language

You have a general idea of what Graph Databases - and Neo4j in particular - are... But how to get started? Read on! This article is part 3 of a growing, ongoing series on Graph Databases and Neo4j If you're new to graph databases, please check out part 1 for an intro and motivation about them. There, we discussed an example about an extremely simple database involving actors, movies and directors... and saw how easy the Cypher query language makes it to answer questions such as "which directors have worked with Tom Hanks in 2016" - questions that, when done with relational databases and SQL, turn into a monster of a query and an overly-complicated data model involving a whopping 5 tables! In this tutorial, we will actually carry out that query - and get acquainted with Cypher and the Neo4j browser interface in the process. This is the dataset we'll be constructing: Get the database in place If you don't already have a database installed locally

Full-Text Search with the Neo4j Graph Database

(UPDATED May 2024) Now that we have discussed a full technology stack based on Neo4j (or other graph databases), and that we a design and implementation available from the open-source project BrainAnnex.org , what next? What shall we build on top? Well, how about Full-Text Search ? This article is part of a growing, ongoing series on Graph Databases and Neo4j Full-Text Searching/Indexing The Brain Annex open-source project includes an implementation of a design that uses the convenient services of its Schema Layer , to provide indexing of word-based documents using Neo4j. The python class FullTextIndexing ( source code ) provides the necessary methods, and it can parse both plain-text and HTML documents (for example, used in "formatted notes"); parsing of PDF files and other formats will be added at a later date. No grammatical analysis ( stemming or lemmatizing ) is done on the text. However, a long list of common word ("stop words") that g

Julian's Polymath Explorations

Search This Blog